Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatr Blood Cancer 2019 Sep;66(9):e27827
Date
07/23/2019Pubmed ID
31330093Pubmed Central ID
PMC6944522DOI
10.1002/pbc.27827Scopus ID
2-s2.0-85067390025 (requires institutional sign-in at Scopus site) 51 CitationsAbstract
Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.
Author List
Athale U, Hijiya N, Patterson BC, Bergsagel J, Andolina JR, Bittencourt H, Schultz KR, Burke MJ, Redell MS, Kolb EA, Johnston DLAuthor
Michael James Burke MD Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdolescentChild
Child, Preschool
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Practice Guidelines as Topic